Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells

AUTOR(ES)

Yi, Ling

FONTE

American Society for Microbiology

RESUMO

Severe acute respiratory syndrome coronavirus (SARS-CoV) is the pathogen of SARS, which caused a global panic in 2003. We describe here the screening of Chinese herbal medicine-based, novel small molecules that bind avidly with the surface spike protein of SARS-CoV and thus can interfere with the entry of the virus to its host cells. We achieved this by using a two-step screening method consisting of frontal affinity chromatography-mass spectrometry coupled with a viral infection assay based on a human immunodeficiency virus (HIV)-luc/SARS pseudotyped virus. Two small molecules, tetra-O-galloyl-β-d-glucose (TGG) and luteolin, were identified, whose anti-SARS-CoV activities were confirmed by using a wild-type SARS-CoV infection system. TGG exhibits prominent anti-SARS-CoV activity with a 50% effective concentration of 4.5 μM and a selective index of 240.0. The two-step screening method described here yielded several small molecules that can be used for developing new classes of anti-SARS-CoV drugs and is potentially useful for the high-throughput screening of drugs inhibiting the entry of HIV, hepatitis C virus, and other insidious viruses into their host cells.

Documentos Relacionados

• Small molecules targeting severe acute respiratory syndrome human coronavirus
• Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
• Mosaic Evolution of the Severe Acute Respiratory Syndrome Coronavirus
• Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human
• Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry